Literature DB >> 22184491

The igf system in carcinogenesis and its implication for cancer therapy.

S Y Yang1, M Winslet.   

Abstract

Entities:  

Year:  2011        PMID： 22184491      PMCID： PMC3224032          DOI： 10.3747/co.v18i6.885

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  17 in total

Review 1.  The somatomedin hypothesis 2007: 50 years later.

Authors:  Solomon A Kaplan; Pinchas Cohen
Journal:  J Clin Endocrinol Metab       Date:  2007-11-06       Impact factor: 5.958

Review 2.  Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: lessons from the first clinical trials.

Authors:  Jordi Rodon; Victoria DeSantos; Robert Jean Ferry; Razelle Kurzrock
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

Review 3.  Biology of insulin-like growth factor binding protein-4 and its role in cancer (review).

Authors:  Rajaraman Durai; Mark Davies; Wenxuan Yang; Shi Yu Yang; Alexander Seifalian; Geoffrey Goldspink; Marc Winslet
Journal:  Int J Oncol       Date:  2006-06       Impact factor: 5.650

Review 4.  The IGF-1 network in lung carcinoma therapeutics.

Authors:  Michalis V Karamouzis; Athanasios G Papavassiliou
Journal:  Trends Mol Med       Date:  2006-10-19       Impact factor: 11.951

5.  Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions.

Authors:  Vassilis G Gorgoulis; Leandros-Vassilios F Vassiliou; Panagiotis Karakaidos; Panayotis Zacharatos; Athanassios Kotsinas; Triantafillos Liloglou; Monica Venere; Richard A Ditullio; Nikolaos G Kastrinakis; Brynn Levy; Dimitris Kletsas; Akihiro Yoneta; Meenhard Herlyn; Christos Kittas; Thanos D Halazonetis
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

6.  Insulin-like growth factor binding protein-4 gene therapy increases apoptosis by altering Bcl-2 and Bax proteins and decreases angiogenesis in colorectal cancer.

Authors:  Rajaraman Durai; Shi Yu Yang; Kevin M Sales; Alexander M Seifalian; Geoffrey Goldspink; Marc C Winslet
Journal:  Int J Oncol       Date:  2007-04       Impact factor: 5.650

Review 7.  Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis.

Authors:  Andrew G Renehan; Marcel Zwahlen; Christoph Minder; Sarah T O'Dwyer; Stephen M Shalet; Matthias Egger
Journal:  Lancet       Date:  2004-04-24       Impact factor: 79.321

8.  Phase I dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors.

Authors:  Paul Haluska; Heather M Shaw; Gretchen N Batzel; Donghua Yin; Julian R Molina; L Rhoda Molife; Timothy A Yap; M Luisa Roberts; Amarnath Sharma; Antonio Gualberto; Alex A Adjei; Johann S de Bono
Journal:  Clin Cancer Res       Date:  2007-10-01       Impact factor: 12.531

Review 9.  Growth Factors and their receptors in cancer metastases.

Authors:  Shi Yu Yang; Anur Miah; Amit Pabari; Marc Winslet
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

10.  Role of insulin-like growth factor binding protein-4 in prevention of colon cancer.

Authors:  Rajaraman Durai; Shi Y Yang; Alexander M Seifalian; Geoffrey Goldspink; Marc C Winslet
Journal:  World J Surg Oncol       Date:  2007-11-07       Impact factor: 2.754
View more
  2 in total

1.  Expression patterns of insulin-like growth factor system members and their correlations with growth and carcass traits in Landrace and Lantang pigs during postnatal development.

Authors:  Zicong Li; Zhenfang Wu; Guangcai Ren; Yunxiang Zhao; Dewu Liu
Journal:  Mol Biol Rep       Date:  2012-12-27       Impact factor: 2.316

2.  A subset of bone marrow stromal cells regulate ATP-binding cassette gene expression via insulin-like growth factor-I in a leukemia cell line.

Authors:  Nadia Benabbou; Pezhman Mirshahi; Camille Bordu; Anne-Marie Faussat; Ruoping Tang; Amu Therwath; Jeannette Soria; Jean-Pierre Marie; Massoud Mirshahi
Journal:  Int J Oncol       Date:  2014-07-29       Impact factor: 5.650
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.